Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1858 1
1866 1
1869 1
1871 2
1873 1
1874 1
1881 1
1882 1
1885 1
1887 2
1888 1
1889 1
1894 1
1897 2
1898 1
1900 2
1901 1
1904 1
1905 2
1906 1
1907 1
1908 1
1911 3
1912 2
1913 2
1914 2
1915 1
1916 2
1919 4
1920 5
1921 1
1922 1
1923 2
1924 1
1925 1
1926 1
1927 1
1928 1
1929 2
1930 2
1931 1
1934 2
1935 9
1938 2
1939 1
1940 4
1941 4
1942 1
1945 3
1946 4
1947 5
1948 19
1949 3
1950 10
1951 13
1952 16
1953 11
1954 23
1955 18
1956 12
1957 12
1958 21
1959 13
1960 22
1961 17
1962 14
1963 66
1964 56
1965 49
1966 36
1967 50
1968 62
1969 51
1970 94
1971 81
1972 101
1973 99
1974 107
1975 233
1976 245
1977 295
1978 284
1979 273
1980 312
1981 249
1982 274
1983 335
1984 365
1985 381
1986 443
1987 447
1988 561
1989 645
1990 708
1991 769
1992 768
1993 860
1994 954
1995 972
1996 1097
1997 1352
1998 1769
1999 2168
2000 2634
2001 2796
2002 3106
2003 3444
2004 3930
2005 4202
2006 4401
2007 4602
2008 5060
2009 5287
2010 5679
2011 6356
2012 6932
2013 7354
2014 8211
2015 8945
2016 9616
2017 10231
2018 11194
2019 12244
2020 14552
2021 16160
2022 16961
2023 12275
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

183,713 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Seok-Il
Page 1
Did you mean seo il ho (5 results)?
The risk factors for Graves' ophthalmopathy.
Cao J, Su Y, Chen Z, Ma C, Xiong W. Cao J, et al. Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1043-1054. doi: 10.1007/s00417-021-05456-x. Epub 2021 Nov 17. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34787691 Review.
Decreasing stressful life events (SLE) may help improve GO. Imbalance in intestinal flora is essential to GO, with Yersinia enterocolitica and Escherichia coli both increased in the digestive tract of the individual with GO. ...An increase in antibodies such …
Decreasing stressful life events (SLE) may help improve GO. Imbalance in intestinal flora is essential to GO, with Yersinia en …
model revisited.
Takada S. Takada S. Biophys Physicobiol. 2019 Nov 29;16:248-255. doi: 10.2142/biophysico.16.0_248. eCollection 2019. Biophys Physicobiol. 2019. PMID: 31984178 Free PMC article. Review.
Then, the theory of protein folding behind Go model, free energy approaches, and off-lattice Go models are reviewed. ...Various extension of Go models is also reviewed. Finally, some publicly available tools to use Go models are listed....
Then, the theory of protein folding behind Go model, free energy approaches, and off-lattice Go models are reviewed. ...Variou …
Insights Into Ferroptosis: Targeting Glycolysis to Treat Graves' Orbitopathy.
Ma R, Gan L, Guo J, Peng Z, Wu J, Harrison AR, Qian J. Ma R, et al. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1994-2003. doi: 10.1210/clinem/dgac163. J Clin Endocrinol Metab. 2022. PMID: 35303084
Inhibition of glycolysis by PDK2 knockdown and dichloroacetic acid (DCA) promoted ferroptosis sensitivity in the GO OFs. The ferroptosis-sensitizing effects of DCA were also observed when the GO OFs were treated with GO-Igs. IGF1R overexpression in the GO
Inhibition of glycolysis by PDK2 knockdown and dichloroacetic acid (DCA) promoted ferroptosis sensitivity in the GO OFs. The ferropto …
GO-based antibacterial composites: Application and design strategies.
Hu C, Yang Y, Lin Y, Wang L, Ma R, Zhang Y, Feng X, Wu J, Chen L, Shao L. Hu C, et al. Adv Drug Deliv Rev. 2021 Nov;178:113967. doi: 10.1016/j.addr.2021.113967. Epub 2021 Sep 10. Adv Drug Deliv Rev. 2021. PMID: 34509575 Review.
Various strategies have been designed to fabricate GO-based composites with antibacterial properties. This review summarized these strategies, divided them into three types and interpreted their antibacterial mechanisms: (i) "GO*/non-GO" type in which GO
Various strategies have been designed to fabricate GO-based composites with antibacterial properties. This review summarized these st …
What Is Trained During Food Go/No-Go Training? A Review Focusing on Mechanisms and a Research Agenda.
Veling H, Lawrence NS, Chen Z, van Koningsbruggen GM, Holland RW. Veling H, et al. Curr Addict Rep. 2017;4(1):35-41. doi: 10.1007/s40429-017-0131-5. Epub 2017 Feb 22. Curr Addict Rep. 2017. PMID: 28357193 Free PMC article. Review.
PURPOSE OF REVIEW: During food go/no-go training, people consistently withhold responses toward no-go food items. ...There is strong evidence suggesting go/no-go training reduces evaluations of no-go food items. SUMMARY: Food go/no …
PURPOSE OF REVIEW: During food go/no-go training, people consistently withhold responses toward no-go food items. ...Th …
Prevention of Graves' ophthalmopathy.
Bartalena L. Bartalena L. Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):371-9. doi: 10.1016/j.beem.2011.09.004. Best Pract Res Clin Endocrinol Metab. 2012. PMID: 22632372 Review.
Accordingly, refrain from smoking should be urged, both as primary prevention (removal of risk factors in Graves' patients without GO), secondary prevention (early detection and treatment of asymptomatic/very mild GO) and tertiary prevention (reduction of complicati …
Accordingly, refrain from smoking should be urged, both as primary prevention (removal of risk factors in Graves' patients without GO
Update on the surgical management of Graves' orbitopathy.
Baeg J, Choi HS, Kim C, Kim H, Jang SY. Baeg J, et al. Front Endocrinol (Lausanne). 2023 Feb 6;13:1080204. doi: 10.3389/fendo.2022.1080204. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36824601 Free PMC article. Review.
The disease severity and activity prompt different treatments, as the signs of GO are heterogeneous, so their management can be very complex. Despite medical advances, the first-line treatment for moderate-to-severe active GO is still glucocorticoids, while surgery …
The disease severity and activity prompt different treatments, as the signs of GO are heterogeneous, so their management can be very …
Graphene oxide nanocolloids.
Luo J, Cote LJ, Tung VC, Tan AT, Goins PE, Wu J, Huang J. Luo J, et al. J Am Chem Soc. 2010 Dec 22;132(50):17667-9. doi: 10.1021/ja1078943. Epub 2010 Nov 24. J Am Chem Soc. 2010. PMID: 21105686
Since the upper size limit is predetermined by the diameter of the nanofiber precursor, the size distribution of the GO nanosheets is much more uniform than that of common GO synthesized from graphite powders. ...Due to higher charge density originating from their h …
Since the upper size limit is predetermined by the diameter of the nanofiber precursor, the size distribution of the GO nanosheets is …
Stable graphene oxide hydrophobic photonic liquids.
Xu YT, Li J, MacLachlan MJ. Xu YT, et al. Nanoscale Horiz. 2022 Jan 31;7(2):185-191. doi: 10.1039/d1nh00523e. Nanoscale Horiz. 2022. PMID: 35014664
However, the poor stability of GO photonic liquids and unsatisfactory dispersibility of GO nanosheets in hydrophobic liquid media have been significant drawbacks to developing photonic materials based on GO. Here, stable GO hydrophobic photonic liquids …
However, the poor stability of GO photonic liquids and unsatisfactory dispersibility of GO nanosheets in hydrophobic liquid me …
Optimal go/no-go ratios to maximize false alarms.
Young ME, Sutherland SC, McCoy AW. Young ME, et al. Behav Res Methods. 2018 Jun;50(3):1020-1029. doi: 10.3758/s13428-017-0923-5. Behav Res Methods. 2018. PMID: 28664243
Despite the ubiquity of go/no-go tasks in the study of behavioral inhibition, there is a lack of evidence regarding the impact of key design characteristics, including the go/no-go ratio, intertrial interval, and number of types of go stimuli, o …
Despite the ubiquity of go/no-go tasks in the study of behavioral inhibition, there is a lack of evidence regarding the impact …
183,713 results
You have reached the last available page of results. Please see the User Guide for more information.